Levetiracetam as a Possible Contributor to Acute Kidney Injury
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference13 articles.
1. eHealthMe. Real world drug outcomes. http://www.ehealthme.com/. Accessed August 31, 2011.
2. Pharmacokinetic profile of levetiracetam: toward ideal characteristics;Patsalos;Pharmacol Ther,2000
3. Safety profile of levetiracetam;Arroyo;Epileptic Disord,2003
4. The clinical pharmacokinetics of the newer antiepileptic drugs: focus on topiramate, zonisamide, and tiagabine;Perruca;Clin Pharmacokinet,1996
5. An open-label study of levetiracetam at individualized doses between 1000 and 3000 mg/day in adult patients with refractory epilepsy;Abou-Khalil;Seizure,2003
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of a physiologically based pharmacokinetic model for levetiracetam in patients with renal impairment to guide dose adjustment based on steady-state peak/trough concentrations;Xenobiotica;2024-02-21
2. Rhabdomyolysis associated with newer-generation anti-seizure medications (ASMs): a real-world retrospective and pharmacovigilance study;Frontiers in Pharmacology;2023-10-02
3. Levetiracetam poisoning with acute kidney injury treated with hemodialysis: A case report;Medicine;2022-09-30
4. Hematological and Renal Effects of Levetiracetam Versus Lamotrigine in Children With Epilepsy: A Randomized Clinical Trial;Disease and Diagnosis;2022-07-01
5. Incidence of Acute Renal Failure in Patients Using Levetiracetam Versus Other Antiseizure Medications: A Voluntary Post-Authorization Safety Study;Drug Safety;2022-06-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3